Filing Details
- Accession Number:
- 0001103021-21-000118
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-11-19 17:20:35
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-19 17:20:35
- Original Submission Date:
- 2021-11-19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-18 | 10,000 | $3.04 | 1,140,595 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This Form 4/A is being filed to amend the Form 4 filed on November 19, 2021 (the "Original Form 4"). The Original Form 4 incorrectly used transaction code "S," instead of transaction code "P."